基于应用程序的1型糖尿病成年人自动饮食分析,使用自动注射胰岛素:一项随机对照试验
Camillo D Piazza1, Céline I Laesser1, Lum Kastrati1
1Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital Bern, Bern University Hospital, University of Bern, Switzerland.
EClinicalMedicine
|October 23, 2025
概括
通过使用自动化胰岛素输送系统,SNAQ应用程序,一种自动化食分析工具,改善了1型糖尿病成年人的葡萄糖控制. 在停止应用程序后,收益没有持续.
科学领域:
- 糖尿病 技术 技术
- 代谢健康 代谢健康
- 数字健康干预措施 数字健康干预措施
背景情况:
- 基于智能手机的自动化餐点分析对1型糖尿病管理具有前景.
- 准确的碳水化合物计数对于自动胰岛素输送系统 (AID) 中的食用胰岛素剂量至关重要.
研究的目的:
- 评估SNAQ应用程序的血糖有效性,用于混合AID治疗的1型糖尿病成年人的饮食管理.
主要方法:
- 一项为期3周的单一中心随机试验将SNAQ应用程序与AID的1型糖尿病成年人通常的饮食管理进行了比较.
- 主要终点是%时间变化 (TIR) 在3.9-10.0mmol/L之间.
主要成果:
- 与对照组相比,SNAQ组显示TIR显著改善 (6.6个百分点,P<0.001).
- 使用SNAQ还导致平均葡萄糖的改善,并减少了超出范围的时间.
- 在时间低于范围,胰岛素剂量或玻尿酸剂频率方面没有观察到显著差异.
结论:
- 短期使用SNAQ自动化餐点分析应用程序有效地改善了使用AID的1型糖尿病患者的葡萄糖控制.
- 干预期结束后,血糖益处没有持续,这表明需要持续使用.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
677
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
677
Insulin Formulations: Types and Delivery
648
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
648
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K


